Samsung Biologics falls 3% after $1.8 billion PolyPeptide acquisition

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocks28 minutes ago

Buy the dip in this Canadian stock: RJ

Investing.com

stocks33 minutes ago

How sustainable is the AI investment boom after Thursday’s selloff?

Investing.com

stocksabout 1 hour ago

Golf-BC Partners seeks control of LIV Golf from Saudi wealth fund, FT reports

Investing.com